retinal pigment epithelial cells
Cell therapyexperimental
Clinical trial activity
5 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2017 (NCT02755428)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Epithelial cellsSupplementation
Epithelial cells supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- retinal pigment epithelial cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05445063 | Phase 1 | Aug 31, 2022 | Capital Medical University |
| NCT04212624 | N/A | Dec 31, 2019 | Eyecure Therapeutics Inc., Jiao Tong University |
| NCT03566147 | Early Phase 1 (Phase 1) | Aug 1, 2018 | Capital Medical University, Eyecure Therapeutics Inc. |
| NCT02755428 | Early Phase 1 (Phase 1) | Apr 1, 2017 | Capital Medical University, Chinese Academy of Medical Sciences |
| NCT03046407 | Early Phase 1 (Phase 1) | Apr 1, 2017 | Chinese Academy of Medical Sciences, Zhengzhou University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 3 | 1 | 1 | 2017 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 2 | 1 | 2017 |
| Eyecure Therapeutics Inc. | For profit | 2 | 1 | 2 | 2018 |
| Jiao Tong University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Zhengzhou University | Academic/Hospital | 1 | 0 | 1 | 2017 |
5 organizations
Page 1 / 1